RIGEL PHARMACEUTICALS INC (RIGL)
Clinical trial NCT06597734 updates: 1. completion date: 2029-08-31 → 2026-06-11 2. primary completion date: 2027-08-31 → 2026-06-11
Clinical trial NCT06597734 updates: 1. completion date: 2029-08-31 → 2026-06-11 2. primary completion date: 2027-08-31 → 2026-06-11
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical